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Korean Society of Cardiovascular Imaging (KOSCI) to meet 
the need for the standardization of image interpretation and 
post-processing of CMR. They not only provide guidance to 
a novice reader about how to interpret CMR images but also 
ensure consistent quality and reproducibility of CMR reports.
This third part of the recommendations focuses on 
tissue characterization modules, including perfusion, late 
gadolinium enhancement (LGE), and T1- and T2 mapping. 
Each module offers visual, and quantitative assessment 
that consist of “What-to-See,” “How-To,” and common 
pitfalls. Quantitative assessment of perfusion imaging that 
is being conducted for research purposes is not included, 
as these recommendations are designed for the application 
of CMR in clinical daily practice. Visual assessment of T1- 
and T2 mapping was not included because of limited use. 
Additionally, example reports for representative cases with 
common disease entities are included to offer practical 
assistance for a beginner.
These guidelines are not mandatory. It is anticipated 
that they will be properly used and adopted according 
to individual hospital situations and clinical scenarios. 
The Consensus Committee hopes that this document can 
contribute to the standardization of image interpretation 
and post-processing in CMR studies.
Myocardial Perfusion Imaging
Visual Assessment
I. What-to-See
1.  Evaluate the presence or absence of inducible 
perfusion defects (Table 1).
2.  If perfusion defects exist, describe location based on 
a 17-segment model, transmural extent, and extent 
of perfusion defects relative to scar on LGE. 
3. Estimate the number of involved segments.
II. How-To
1.  Display both rest and stress perfusion images side-
by-side, using a stack or cine mode. If possible, also 
display corresponding LGE images.
2.  Adjust window width and level. Avoid “overspilling” 
of the left ventricular (LV) cavity signal into the 
myocardium.
3.  Apply the same window setting to all images.
4.  Compare rest and stress images to identify relative 
hypoperfusion.
III. Pitfalls
1.  Dark banding (rim) artifacts: Subendocardial dark 
banding artifacts are common sources of false-
positive interpretation (Fig. 1, Supplementary Movie 
1). Table 1 summarizes differential points (1, 2). 
2.  Multi-vessel disease: Balanced multi-vessel disease 
can result in subendocardial hypoperfusion in most, 
or all segments (Fig. 2, Supplementary Movie 2), 
which can lead to false-negative interpretation, 
or misdiagnosis of microvascular disease, as visual 
analysis reflects a relative myocardial perfusion 
(3). On visual analysis, a discernible signal 
gradient between subendocardial and subepicardial 
Table 1. Comparison between True Inducible Perfusion Defect and Dark Banding Artifacts Adapted from Reference (2)
True Inducible Perfusion Defect Dark Banding Artifacts
Timing of appearance
Occurs first when contrast reaches LV myocardium
Typically occur first and are most prominent when 
  contrast arrives in LV blood pool
Present at stress but not at rest
Present at stress and at rest with no corresponding 
  scar
Signal
Shows increase in signal compared with baseline, 
  even if it is small
Show reduction in signal compared with baseline 
  myocardial signal
Duration
Persists after peak myocardial enhancement and 
  usually for more than 4 heart beats
Persist only transiently before peak myocardial 
  contrast enhancement and often for less than 
  6 heart beats
Size More than one pixel wide Approximately one pixel wide
Location and changes
Most noticeable in subendocardial portion 
  of myocardium. Often exhibits as transmural defect. 
  Over time, defect regresses from epicardium toward 
  subendocardium
Appear in subendocardial portion of myocardium 
  and in phase-encoding direction
Conformation to coronary 
  vascular territory
Corresponds to distribution territory of coronary
  arteries
No
LV = left ventricular
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Fig. 1. Dark banding artifact in 18-year-old man. Defect (arrows) is approximately one pixel wide, prominent in phase-encoding direction 
(right-left in this case), and already appears before contrast reaches myocardium. Even though this defect is seen on both stress and rest 
perfusion images, there is no delayed enhancement in corresponding region on LGE image. LGE = late gadolinium enhancement
Fig. 2. Three-vessel disease in 70-year-old man. Ring-like subendocardial perfusion defect (arrowheads) is seen on stress, and disappears 
on rest images (upper row). Differentiation from microvascular disease may be challenging. Patient had multifocal severe stenosis (arrowheads) 
at left anterior descending and left circumflex coronary arteries. Right coronary artery angiogram (on right lower) shows total occlusion (arrow) 
at proximal segment, and distal segment (arrow) reconstituted via big septal branch is seen on left coronary angiogram (on left lower) (Courtesy 
of Sung-A Chang, Samsung Medical Center).
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myocardium may be seen in multi-vessel disease. 
Quantitative analysis of absolute coronary blood flow 
can help to further reveal diminished myocardial 
perfusion reserve in multi-vessel disease (2, 4). 
3.  Microvascular disease: Diseases that affect the 
myocardial microvasculature, such as diabetes 
mellitus or systemic hypertension (also called 
“syndrome X”), may result in subendocardial 
concentric reduction in perfusion, traversing 
coronary territories (5) (Fig. 3, Supplementary Movie 
3). Differentiation from multi-vessel disease or dark 
banding artifacts can be challenging.
4.  Hypertrophic cardiomyopathy (HCM): Patchy or 
subendocardial inducible ischemia can be seen in 
HCM (Fig. 4, Supplementary Movie 4). Intramural 
coronary artery disease (CAD), which is pathologically 
characterized by smooth muscle thickening and 
luminal narrowing, may be attributable to an 
ischemia in HCM (6). The fact that fibrosis is present 
within the area of an ischemia, and is smaller than 
the area of an ischemia, supports this speculation (7). 
5.  Delayed perfusion in a patient who is post bypass 
graft: A delayed perfusion due to long graft pathway 
in a post bypass graft can mimic a true perfusion 
defect on myocardial stress MRI (8). The differential 
points are extent and duration: delayed perfusion 
Fig. 3. Microvascular disease in 73-year-old man with 20-year history of diabetes mellitus. Patient complains of chest pain. Invasive 
coronary angiography shows insignificant findings. Note global subendocardial perfusion defect (arrowheads), which is more than one pixel wide 
on stress perfusion images.
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from a long bypass graft pathway is transmural, 
while in true perfusion defects, hypoenhancement 
is non-transmural in most cases, and true perfusion 
defects tend to last longer. Additionally, a delayed 
perfusion from a long bypass graft pathway appears 
on both stress and rest images. Semi-quantitative 
and quantitative measurements are helpful to 
differentiate between them, because perfusion 
parameters of a delayed perfusion from a long graft 
are not deteriorated, and like those of the normal 
myocardium (Fig. 5, Supplementary Movie 5).
6.  Overcalling of inducible ischemia: Certain conditions, 
such as microvascular obstruction (MVO) in acute 
myocardial infarction, infarcted tissue, thrombus, 
and tumor, can appear as a hypo-signal on stress 
perfusion imaging. Evaluating them with LGE 
images is important to prevent misinterpretation as 
inducible ischemia.
7.  Inadequate effect of vasodilator stress: Caffeine is a 
nonspecific competitive antagonist of all adenosine 
receptor subtypes; therefore, it may hamper the 
coronary vasodilatory effects of adenosine agonists 
(9). Despite the conflicting and limited published 
data, current guidelines recommend that caffeine 
be withheld for 12 hours prior to vasodilator stress 
myocardial perfusion imaging (10).
Semi-Quantitative Assessment
I. What-to-See 
1.  Analysis methods of the signal intensity (SI) profile 
of myocardial dynamic perfusion CMR data, without 
estimating the absolute myocardial blood flow (11) 
(Fig. 6).
2.  Maximal up-slope (12): May be normalized to LV up-
slope.
3.  Time to peak SI of the myocardial SI profile (13).
4.  The up-slope integral (14): Area under the SI–time 
curve until arterial input function (AIF) peak, also 
Stress Rest LGE
Fig. 4. Inducible ischemia in 52-year-old woman with septal-type HCM. Inducible, global, subendocardial perfusion defects (arrows) are 
present in mid to apical segments, and extent of defects is greater in hypertrophied septum of left ventricle on stress images. Compared to LGE 
images, fibrosis (arrowheads) exists within area of ischemia and is smaller than perfusion defects. HCM = hypertrophic cardiomyopathy
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normalized to the up-slope integral of LV.
5.  Myocardial perfusion reserve index (15): Ratios of 
stress value divided by the rest value of each above 
parameter.
II. How-To
1.  Select an image from the dynamic series with good 
contrast.
2.  Draw LV endocardial and epicardial contours on this 
image manually or automatically.
3.  Propagate contours to all other dynamic images.
4.  Place a separate region of interest (ROI) in the LV 
blood pool. Preferably, the basal slice is used without 
including papillary muscles.
5.  Select a reference point in the LV myocardium for 
segmentation (usually the right ventricular [RV] 
insertion point).
6.  Generate time-intensity curve from myocardial 
segments and LV blood pool.
7.  Make sure to substrate baseline signal in the time-
intensity curve.
8.  Time window for calculation starts from the contrast 
arrival in the LV.
9.  Some MR vendors provide inline post-processing of 
up-slope mapping after automatic motion correction 
and registration at each perfusion imaging. 
10.  Dedicated software provides regional values for 
myocardial segments, and LV blood pool, according 
to American Heart Association classification (Fig. 7).
11.  Consider separate calculation of endocardial and 
epicardial layers, and repeat analysis.
III. Pitfalls
1.  SI may vary according to the distance from coil.
2.  No absolute measurement of myocardial blood flow 
derived.
3.  Confounding effect of the quantity in the 
denominator, which serves the role of normalization, 
causes unreliable results. For example, in patients 
with hypertension, resting blood flow may be 
abnormally elevated in proportion to the rate-
pressure product (10). Evaluating the myocardial 
perfusion reserve from a ratio in this situation would 
be inaccurate.
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Fig. 6. Simple diagram exhibiting semi-quantitative perfusion 
parameters. AIF = arterial input function, SI = signal intensity
Fig. 5. Inducible ischemia and delayed perfusion in 50-year-old man who underwent coronary bypass graft surgery. Delayed 
perfusion (arrow) due to long bypass graft is transmural and appears on both stress and rest images, while inducible perfusion defect (arrowhead) 
is subendocardial, lasts longer, and appears only on stress perfusion image. Invasive coronary angiography shows long, saphenous venous Y graft 
(arrow) to posterior descending coronary artery (Adapted from Kim et al. Korean J Radiol 2014;15:188-194 (8)).
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Quantitative Assessment
I. What-to-See 
1.  Estimation of absolute myocardial blood flow (unit: 
mL/min/g) by analyzing the SI profile of myocardial 
dynamic perfusion CMR data (11).
II. How-To
1.  Quantitative analysis is performed in the same 
manner as the semi-quantitative analysis.
2.  AIF to analyze absolute myocardial blood flow is 
required, and can be derived from the ROI in the LV 
blood pool. 
3.  Generally, there are two approaches that can be used 
to quantify myocardial blood flow using contrast-
enhanced CMR perfusion data: model-based (16) and 
model-independent methods (17). 
III. Pitfalls
1.  Use of an adequate pulse sequence and contrast 
regime is the prerequisite for reliable quantification.
2.  Correction of the AIF for saturation effects, resulting 
in the nonlinearity of the relationship between SI 
and contrast concentration.
3.  Dual-bolus injection method that uses diluted 
contrast agent as pre-bolus before the main bolus 
(18, 19): an initial minibolus (i.e., 0.0025 mmol/
kg) to maintain blood pool linearity followed by a 
high dose (i.e., 0.05 or 0.10 mmol/kg) to maximize 
myocardial signal-to-noise ratio (SNR) 10 or 20 
seconds later. Low doses of contrast to minimize 
saturation effects: 0.025–0.050 mmol/kg for 
quantification is usually used, strictly less than 0.03 
mmol/kg.
4.  Dual-T1 sensitivity method with high dose, single 
injection (20): This method uses a low-resolution 
sequence with a short saturation-recovery time to 
measure AIF and a high-resolution sequence with a 
long saturation-recovery time to assess myocardial 
output within each R-R interval.
5.  The optimal solution to the nonlinearity of the 
myocardium has not been defined yet because of 
more complex challenges.
6.  Use of an intravascular contrast agent instead of 
an extracellular agent can simplify the estimation 
of blood flow, due to absence of leakage into the 
interstitial space (zero permeability surface area 
product), and it can improve the accuracy of blood 
flow estimates (21).
7.  Baseline correction: Background signal should be 
subtracted before contrast enhancement.
8.  At least 10 minutes interval after contrast injection 
to minimize the influence of the first perfusion scans.
Fig. 7. Example of semi-quantitative perfusion analysis using dedicated software. Regional maximal up-slope values are demonstrated 
based on 17-segment model on time–SI profile. Blue dot in anterior junction of right ventricular insertion point indicates reference point in left 
ventricular myocardium for segmentation.
Rest Stress
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Late Gadolinium Enhancement Imaging
Visual Assessment
I. What-to-See
1.  Identify irreversibly injured myocardial tissue.
2.  If delayed enhancement exists, describe the 
location based on a 17-segment model, pattern of 
LGE (subepicardial, intramural, subendocardial, or 
transmural), transmural extent, viability, and the 
presence of MVO or thrombus. 
3.  Estimate the number of segments involved.
II. How-To
1.  Determine the optimal inversion time (TI) using 
initial TI scout imaging, to obtain a good-quality 
LGE image. The optimal TI differs depending on 
the contrast material clearance from the normal 
myocardium. In general, a slightly too long TI is 
preferred over a slightly too short TI (22) (Fig. 8). 
2.  Use phase-sensitive inversion recovery (PSIR) 
imaging. PSIR imaging is less sensitive to TI, and 
shows infarct tissue as bright, and always shows the 
normal myocardium as dark, regardless of the TI. 
3.  Adjust window width and level to avoid noise, and to 
prevent the LGE regions to be cut-off.
4.  Determine the presence of LGE. If high SI is as bright 
as the LV blood pool, it is considered as LGE. 
5.  Assess the pattern of LGE (23, 24). CAD type is 
typically seen as subendocardial involvement that 
corresponds to a coronary artery perfusion territory 
(Fig. 9). Non-CAD type is usually described as 
subendocardial sparing and myocardial enhancement 
restricted to the mid-wall or epicardium (Fig. 10).
6.  Evaluate the average transmural extent of LGE. In 
each of 17 standardized myocardial segments, the 
Fig. 8. Role of TI in LGE imaging. 
Left image (A) shows wrong nulling of normal myocardium that is shown to be darkest at border with higher SI centrally. These findings signify 
that degree of LGE may be underestimated if TI is too short. Right image (B) shows optimal nulling of myocardium with repeated image taken at 
longer TI and demonstrates larger LGE area in inferior wall (arrows). TI = inversion time
A B
Fig. 9. Pattern assessment in LGE image in patient with 
coronary artery disease. Most important finding of ischemic pattern 
is that LGE lesion follows coronary artery distribution. This patient 
shows delayed enhancement (arrows) at mid inferolateral wall of left 
ventricular myocardium, indicating left circumflex artery territory. 
Lesion of ischemic pattern starts at endocardium extending toward 
epicardium, according to concept of wave front phenomenon of 
myocardial death. 
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LGE region is scored with a five-point scale (0%, 
1–25%, 26–50%, 51–75%, 76–100%) (25). 
7.  Compare LGE image with cine and perfusion images 
to categorize ischemia and viability (26).
8.  Identify MVO or thrombus, and distinguish it from 
viable myocardium.
A.  MVO is shown as a central hypo-enhanced region 
within an avidly hyper-enhanced region of 
infarcted myocardium on LGE image (Fig. 11). 
Although the appearance of MVO on first-pass 
perfusion and early and LGE sequences is similar, 
LGE is a more accurate predictor of adverse 
ventricular remodeling and future major adverse 
cardiovascular events (27).
B.  LV thrombus occurs at the endocardial surface 
area covering the site of myocardial infarction. In 
patients with MVO, the low SI on LGE is localized 
within the myocardium. However, in patients with 
thrombus, the low SI on LGE is observed within 
the cavity adjacent to the wall of the myocardium 
(28).
III. Pitfalls
1.  Bright ghosting artifacts can occur in areas 
within the field-of-view that have long T1 species 
(cerebrospinal fluid, pericardial or pleural effusion, 
and gastric fluid), poor electrocardiography gating, 
and poor breath-holding (29). Decreasing scan time 
(single shot technique), or increasing the average 
DCM
HCM
Sarcoidosis
Amyloidosis
Fig. 10. Short-axis MR images demonstrate LGE pattern in various types of non-ischemic cardiomyopathy. There is mid-wall 
enhancement in basal, interventricular, septal wall of myocardium in patient with DCM (black arrows), epicardial enhancement in patient with 
sarcoidosis (white arrows), patchy enhancement at junction of both ventricles in patient with HCM (white arrows), and global subendocardial 
enhancement in patient with amyloidosis (white arrows). DCM = dilated cardiomyopathy
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factor is helpful in reducing bright ghosting artifacts.
2.  On non-PSIR images, tissues with long T1 value may 
appear to be enhanced (30). 
3.  It can be difficult to discriminate no-reflow zones or 
LV thrombus from viable myocardium. Adding post-
contrast cine imaging with LGE may be helpful in the 
evaluation. 
4.  If the contrast enhancement is reduced, 
interpretation of additional sequences may be 
required. The contrast between the infarcted 
myocardium, and blood in the inversion recovery 
image relies on variables such as blood velocity, 
dosage of contrast material, time from gadolinium 
administration, clearance rate of contrast media, and 
imaging parameters. The solution to these problems 
includes using multiple contrasts, such as T1 and T2, 
or using blood suppression techniques (31, 32).
Semi-Quantitative Assessment
I. What-to-See 
1.  Semi-automated analyses that measure the LGE 
extent and/or “gray-zone” extent under the premise 
of subjective visual assessment that is still needed to 
identify poor nulling, no-reflow zones, artifacts, etc. 
and to delineate endocardial and epicardial borders.
II. How-To
1.  Several different methods of describing LGE extents 
are documented in the literature, including manual 
planimetry, the “n”-standard deviation (SD) 
technique, and full width at half maximum (FWHM) 
technique.
2.  Manual planimetry: It is considered as a subjective 
technique, because all the measurements depend on 
a human decision.
A.  Outline endocardial and epicardial borders.
B.  Perform manual planimetry of the LGE in each 
short-axis slice.
C.  Obtain a sum of LGE areas multiplied by slice 
thickness plus inter-slice gap, corresponding to the 
volume of scar/fibrosis. 
D.  Multiplying this total LGE area by the specific 
gravity of myocardium supplies the approximate 
LGE weight, and the ratio of LGE to normal 
myocardium can be calculated.
3.  The “n”-SD technique: The rule of thumb is to 
select the reference myocardium and an appropriate 
threshold method that produces the results matched 
to “radiologist’s eye.”
A.  Outline endocardial and epicardial borders to draw 
the myocardial ROI.
B.  Select a normal “remote” (dark) ROI in the 
myocardium for the reference SI (mean and SD). 
C.  The software will distinguish the areas within the 
myocardial ROI with a SI greater than a certain 
mean ± SD threshold, which is defined by the 
operator. 
D.  Select a threshold between the normal myocardium 
and the area of LGE. 
1)  The relative SNR between scar tissue and normal 
myocardium varies according to the type and 
dose of contrast agent, time after injection, type 
of sequence, field strength, and the underlying 
injury itself.
2)  There is no fixed cut-off value. Recommended 
semi-automatic thresholding: n + 5 SD in 
infarction and n + 3 SD in myocarditis (33, 34) 
(Fig. 12).
3)  The LGE area within the myocardium is 
determined automatically.
4)  Automated thresholding may provide better 
reproducibility after appropriate standardization.
5)  Manually modify to include no-reflow zones, 
except for artifacts and LV blood pool, which are 
Fig. 11. Short-axis LGE image in 49-year-old man with 
exertional chest pain performed 5 days after primary 
percutaneous coronary intervention to left anterior descending 
artery. Full-thickness infarct within anterior and anteroseptal left 
ventricular mid-wall with microvascular obstruction (arrows) is shown 
as central hypo-enhanced region within avidly hyper-enhanced region 
of infarcted myocardium on LGE image.
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caused by an error in drawing the endocardial 
contour. 
6)  It is receptive to spatial variations of the 
radiofrequency (RF) field, generated by the 
surface coil.
4.  The FWHM technique: The rule of thumb is to 
appropriately determine both, the reference and LGE 
myocardium, so that the results match with those 
of the “radiologist’s eye.” The location and size of 
ROI for the reference and LGE myocardium can be 
adjusted to match the results with those of the 
“radiologist’s eye.”
A.  Outline the endocardial and epicardial borders to 
draw the myocardial ROI.
B.  Evaluate whether the LGE is present. If there is 
an LGE lesion, choose an ROI that contains the 
“maximum” signal.
1)  Threshold is set at half of the maximal SI within 
the scar.
2)  The FWHM technique is less receptive to spatial 
variations of the RF field generated by the 
surface coil than the “n”-SD technique (35).
3)  The FWHM technique is more reproducible 
compared to the “n”-SD technique (36, 37). 
Fig. 12. “n”-SD technique for quantifying LGE extent. LGE image in 57-year-old man with chest pain shows subendocardial infarction 
at basal inferior wall of myocardium (arrows). Endocardial and epicardial borders are outlined and region of interest within remote dark 
myocardium as reference is drawn. According to threshold between enhanced and unenhanced myocardium selected, extent of LGE varies 
significantly as shown in these color maps. SD = standard deviation
4 SD
5 SD2 SD
3 SD 6 SD
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4)  The accuracy of the FWHM technique may be 
reduced compared to the “n”-SD technique if 
LGE is patchy or gray, because the technique 
presumes a bright LGE core.
C.  Manually modify to include no-reflow zones except 
for artifacts and LV blood pool, which are caused 
by an error in drawing the endocardial contour.
T1-Weighted Imaging
Quantitative Assessment
I. What-to-See
1. Native T1
A.  ‘Native T1’ means tissue longitudinal relaxation 
time (T1) values, without using contrast agent 
(38).
B.  T1 is affected by water (edema), proteins, and 
other T1-altering substances (lipid, iron) (39-
42). T1 is sensitive to change of composition, and 
structure of myocardial tissue.
C.  It may also be used with terms such as “native 
myocardial T1,” “pre-contrast T1,” or “non-contrast 
T1.” “Native T1” or simply “T1” is used in this 
paper.
D.  Native T1 mapping is one of the CMR techniques 
that provides a parametric map in which each pixel 
is encoded with a native T1 value (43).
2. Post-contrast T1
A.  “Post-contrast T1” means tissue longitudinal 
relaxation time values with the use of a contrast 
agent.
B.  Post-contrast T1 mapping is a CMR technique that 
provides a parametric map in which each pixel is 
encoded with a post-contrast T1 value (40).
3.  Extracellular volume (ECV) fraction or myocardial ECV
A.  ECV reflects the fraction of the volume occupied by 
extracellular space of heart tissues (38). It can be 
altered by diseases involving the myocardium.
B.  Measurements of ECV are obtained by measuring 
the native and post-contrast T1 of the myocardium 
and blood.
C.  Using the relationship between the fraction 
of plasma and the change in T1 relaxation 
rate of blood before and after contrast agent 
administration, the change in T1 relaxation rate in 
myocardial tissue can be used to estimate ECV (44, 
45). This can be expressed as follows: 
 Post-contrast T1 mapping is a CMR technique that provides a 
parametric map in which each pixel is encoded with a post-contrast T1 
value (40). 
 Extracellular volume (ECV) fraction or myocardial ECV 
 ECV reflects the fraction of the volume occupied by extracellular space 
of heart tissues (38). It can be altered by diseases involving the 
myocardium. 
 Measurements of ECV are obtained by measuring the native and post-
contrast T1 of the myocardium and blood. 
 Using the relationship between the fraction of plasma and the change in 
T1 relaxation rate of blood before and after contrast agent 
administration, the change in T1 relaxation rate in myocardial tissue 
can be used to estimate ECV (44, 45). This can be expressed as follows:  
ECV = (1 - hematocrit) ×  
1
Postcontrast?T1?myocardium
 - 1
Native?T1?myocardium
1
Postcontrast?T1?blood
 - 1
 Native?T1?blood
 
 ECV map can be formed by encoding the ECV value at each pixel (46). 
 ECV measures and predicts the space occupied by the extracellular 
matrix, which is also associated with the collagen volume fraction (47-
49). 
 Unless there is infiltrative disease or myocardial edema, it is associated 
with myocardial fibrosis, and myocardial remodeling. 
 How-To 
 Preparation 
 Because normal values may vary due to various causes (sex/age, 
D.  ECV map can be formed by encoding the ECV value 
at each pixel (46).
E.  ECV measures and predicts the space occupied by 
the extracellular matrix, which is also associated 
with the collagen volume fraction (47-49).
F.  Unl ss there is infiltrative disease or yocardial 
edema, it is associated with myocardial fibrosis, 
and myocardial remodeling.
II. How-To
1. Preparation
A.  B cause normal v lues may vary due to various 
causes (sex/age, vendor, field strength, sequence 
contrast, etc.), normal values should be measured 
in advance on each MR equipment, with more than 
10 healthy volunteers (38).
B.  Hematocrit is essential for measuring ECV. A 
process that can perform the blood test near the 
time of CMR is needed. As a noninvasive test, the 
method of obtaining the synthetic ECV using the 
longitudinal relaxation rate of blood may be used; 
however, further research is needed (50-52).
2. Visual check
A.  T1 and ECV maps should be displayed with 
the appropriate color or grayscale, so that the 
difference from normal is clearly visible, and kept 
the same within the study.
B.  It is necessary to check whether the slices 
obtained before and after contrast are matched 
with each other. An error may occur in ECV 
measurement if they do not match.
3. Measurement; drawing ROI
A.  ROI should be drawn to minimize partial volume 
effects.
B.  When drawing the ROI, a sufficient distance should 
be secured from the unclear tissue interface, such 
as between myocardium and blood.
C.  It is necessary to decide whether to include LGE 
in the drawing area and record whether it is 
included in the reading. For example, patients with 
non-ischemic myocardial disease can be drawn 
to include non-ischemic LGE except for those 
considered as old infarction.
D.  Measurement technique
1)  Singular measurement: Either measure once in 
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the septum or measure the total myocardium on 
the short axis and, then, find the mean value. 
However, if the ROI does not match the pathologic 
lesion, the disease may be missed (Fig. 13).
2)  The 16 segments approach: This measures 
the total myocardium. However, there can be 
problems with off resonance or partial volume 
error (53) (Fig. 14).
T2-Weighted Imaging
Visual Assessment
I. What-to-See
1.  The aim is to detect the increased SI area, indicating 
increased free water content.
2.  Indications are acute coronary syndromes, including 
myocardial infarction (Fig. 15), acute myocarditis 
(Fig. 16), sarcoidosis, tako-tsubo cardiomyopathy, 
HCT
Native T1 Post T1
ECVBlood BloodMyocardium Myocardium
41.5% 1969 ms 1419 ms 336 ms 480 ms 32.7%
Fig. 13. T1 mapping images of 60-year-old woman with HCM. After obtaining native T1 and post-contrast T1 values in myocardium and 
blood, values and HCT are inserted into ECV formula. HCM is usually characterized by high T1 value and high ECV. This patient also had high T1 
value of 1419 ms and high ECV value of 32.7%. ECV = extracellular volume, HCT = hematocrit
Fig. 14. T1 mapping images of 43-year-old male with Fabry disease. After drawing endocardial contour and epicardial contour in native 
T1- and post T1 mapping images, T1 value and ECV are calculated. Fabry disease has special characteristics of low T1 value and normal ECV. This 
patient also had low T1 value of 1089.3 ms and normal ECV value of 23%.
Native T1 map Native T1
Average: 1089.3 ms Average: 23%
ECV
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and heart transplantation rejection.
3.  Cleary-detectable high SI area following anatomical 
borders, and expected regional distribution pattern 
is suggestive of myocardial edema.
II. How-To
1.  Identify appropriate images.
2.  Modify image contrast and brightness to minimize 
SI in the background, and reduce maximal SI in the 
highest SI area, to remove the “over-shining” effect.
3.  Check for artifacts, such as surface coil reception 
field inhomogeneity, low SI artifacts due to 
arrhythmia or myocardial motion, and high SI 
artifacts due to slow flowing blood, especially in 
dark-blood triple-inversion recovery spine echo (short 
tau inversion recovery, turbo inversion recovery 
magnitude) images.
Semi-Quantitative Assessment
I. What-to-See
1.  It is a method of SI quantification with reference 
region that can reduce the impact of artifacts.
II. How-To
1.  Draw the largest ROI for short-axis views in the 
serratus anterior muscle (global SI), and the ROI in 
the affected myocardial area (regional SI).
2.  Divide the regional SI by global SI.
3.  Cut-off value of SI ratio is 1.9 in dark-blood triple-
inversion recovery spine echo images (54).
Quantitative Assessment
I. What-to-See
1.  It is a parametric map, in which each pixel is 
encoded with a T2 value.
Fig. 15. Acute myocardial infarction in 51-year-old man with chest pain. Area of increased SI on T2WI was correlated with area of 
delayed enhancement on LGE image. T2WI = T2-weighted image
Fig. 16. Acute myocarditis in 40-year-old man with fever. Increased SI observed in global myocardium on T2WI, and SI ratio of 
myocardium to serratus anterior muscle was increased to 2.0.
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II. How-To
1. Work flows are the same as T1 mapping.
T2* Imaging
Quantitative Assessment
I. What-to-See
1.  The aim is to detect myocardial hemorrhage or iron 
deposition (Fig. 17).
2.  If iron burden is increasing, rapid signal loss 
develops along with increasing echo time (TE).
II. How-To
1.  Draw the ROI of the ventricular septum with 
avoidance of blood pool, and proximal blood vessels 
(full-thickness ROI).
2.  Calculate mean myocardial SI from the ROI.
3.  Check SI with changes of TE, and get a mono-
exponential curve.
4.  Truncate the curve by removing later TEs, to avoid 
underestimating T2* in patients with heavy iron 
overload (55).
5.  Cut-off value of T2* at 1.5 tesla is 40 ms (56).
6.  T2* < 20 ms indicates cardiac iron overload, and T2* 
< 10 ms indicates increased risk of developing heart 
failure (57, 58).
7.  T2* evaluation at 3 tesla is not recommended.
Sample Report
These sample reports are written from examples of 
diseases that are often clinically encountered. Each report 
was written by committee members in consensus. These 
reports are just an example, not a guideline. It can be 
applied differently depending on the clinical situation of 
Fig. 17. Beta-thalassemia in 35-year-old man. Substantial signal loss occurred at TE of 8.3 ms, and measured T2* value was 3.8 ms.  
TE = echo time
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hospital, patients and diseases.
Example 1: HCM
History: 45-years old, male, palpitation
Body weight, 73 kg; height, 180 cm; body surface area 
(BSA), 1.91 m2; hematocrit, 44.7%
Imaging protocol:
Scout, cine MRI (4-chamber, 2-chamber, left ventricular 
outflow tract [LVOT], and short-axis), delayed enhancement 
MRI (4-chamber, 2-chamber, and short-axis), T1 mapping 
pre/post-contrast (short axis), and T2 mapping (short axis) 
on 3T MRI.
I. Imaging findings (Fig. 18): 
1. Morphological evaluation on cine MRI 
A.  Thickening of LV myocardium at the anterior and 
anteroseptal wall of basal to mid cavity level.
B. Maximal thickness: 2.5 cm at the anteroseptum of 
mid LV
C.  No evidence of LVOT obstruction.
2. Delayed enhancement
A.  Ill-defined patchy delayed enhancement in 
hypertrophied segments.
3. T1 mapping
A.  Increased native T1 value (1273.7), and increased 
ECV fraction (31.6 %) in thickened LV myocardium.
4. Ventricular function on cine MRI
A. LV quantitative assessment
1)  Papillary muscle as ventricular cavity
2)  Ejection fraction (EF), 77.2%; end-diastolic 
volume (EDV), 124.9 mL (65.4 mL/m2*); end-
systolic volume (ESV), 28.5 mL (14.9 mL/m2*); 
stroke volume (SV), 96.4 mL
*BSA-indexed value
B. RV quantitative assessment
1) Short axis method
2)  RV EF, 67.1%; EDV, 106.6 mL (55.8 mL/m2*); ESV, 
Fig. 18. Images for HCM sample report.
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35.1 mL (18.4 mL/m2*); SV, 71.5 mL
*BSA-indexed value
Example 2: Ischemic Heart Disease
History: 64-years old, male
Body weight, 76 kg; height, 180 cm; BSA, 1.95 m2
Imaging protocol:
Scout, cine MRI (4-chamber, 2-chamber, LVOT, and short-
axis), delayed enhancement MRI (4-chamber, 2-chamber, 
and short-axis) on 3T MRI.
I. Imaging findings: 
1. Conclusion
A. Impaired LV global systolic function (EF, 45.9%)
Normal LV cavity size (left ventricular end-diastolic 
volume index, 79.1 mL/m2)
B. Delayed enhancement (Fig. 19)
75–100% transmural infarct at LV mid anterior and 
septal wall, apical anterior, septal, and inferior wall, 
and apex
Associated with large amount of no reflow zone
→ suggesting acute myocardial infarction of left 
anterior descending artery territory
C.  Regional wall motion abnormality (+)–see findings
D. Pericardial effusion
2. Findings
A. Delayed enhanced segments
1) Basal anterior (-)
2) Basal anteroseptal (-)
3) Basal inferoseptal (-)
4) Basal inferior (-)
5) Basal inferolateral (-)
6) Basal anterolateral (-)
Fig. 19. Images for ischemic cardiomyopathy sample report.
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7)  Mid anterior (+): 100% transmurality, 4/4 of area
8)  Mid anteroseptal (+): 100% transmurality, 4/4 of 
area
9)  Mid inferoseptal (+): 75% transmurality, 2/4 of 
area
10)  Mid inferior (-) 
11)  Mid inferolateral (-)
12)  Mid anterolateral (-)
13)  Apical anterior (+): 75% transmurality, 4/4 of 
area
14)  Apical septal (+): 75% transmurality, 4/4 of area
15)  Apical inferior (+): 75% transmurality, 4/4 of 
area
16)  Apical lateral (+): 75% transmurality, 4/4 of area
17)  Apex (+)
B.  Motion (1, normokinesia; 2, hypokinesia; 3, 
akinesia; 4, dyskinesia; 5, aneurysm) 
1) Basal anterior: 1
2) Basal anteroseptal: 1
3) Basal inferoseptal: 1
4) Basal inferior: 1
5) Basal inferolateral: 1
6) Basal anterolateral: 1
7) Mid anterior: 3
8) Mid anteroseptal: 3
9) Mid inferoseptal: 2
10) Mid inferior: 1
11) Mid inferolateral: 1
12) Mid anterolateral: 1
13) Apical anterior: 3
14) Apical septal: 3
15) Apical inferior: 3
16) Apical lateral: 2
17) Sum of cardiac motion index = 28
C.  LV function measurement (absolute [normalized]) 
1) EF: 45.9% 
2) EDV: 154.5 (79.1) mL
3) ESV: 83.6 (42.8) mL
4) SV: 70.9 (36.3) mL
5) Cardiac output: 5.18 (2.73) L/min 
6) Average myocardial mass: 184.3 (94.4) g 
7) BSA: 1.95 m2 
8) Heart rate: 73 bpm
D.  Forward volume/reverse volume/net forward 
volume (mL)
1) Ascending aorta: 61.31/1.77/59.54
2)  Descending thoracic aorta (dTA): 
43.36/1.09/42.27
3) Superior vena cava (SVC): 25.05/2.31/22.74
4) dTA + SVC: 68.41/3.40/65.01
Supplementary Materials
The Data Supplement is available with this article at 
https://doi.org/10.3348/kjr.2019.0411.
Supplementary Movie Legends
Movie 1. Dark banding artifact on stress (a) and rest (b) 
perfusion images in an 18-year-old man.
Movie 2. Three-vessel disease in a 70-year-old man. 
Ring-like subendocardial perfusion defect is seen on stress 
(a) and disappears on rest images (b). Differentiation from 
microvascular disease may be challenging (Courtesy of 
Sung-A Chang, Samsung Medical Center).
Movie 3. Microvascular disease in a 73-year-old man who 
has 20-year history of diabetes mellitus on stress (a) and 
rest (b) images.
Movie 4. An inducible ischemia in a 52-year-old woman 
with septal-type HCM on stress (a, b) and rest (c, d) 
images.
Movie 5. An inducible ischemia and delayed perfusion 
in a 50-year-old man who underwent coronary bypass graft 
surgery on stress (a) and rest (b) images (Adapted from Kim 
et al. Korean J Radiol 2014;15:188-194 (8)).
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